Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor - Prospective randomized controlled trial on efficacy and safety by combined analgesics at sedative bronchoscopy using a BIS monitor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032468

Enrollment

100

Registered

2018-05-03

Start date

2018-05-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral lung lesion

Interventions

Administration of midazolam during bronchoscopy Administration of midazolam and fentanyl during bronchoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Over 20 years old and under 90 years 2) Adaptation of bronchoscopy (EBUS-GS) 3) Written consent has been obtained

Exclusion criteria

Exclusion criteria: 1) History of severe drug allergy 2) Contraindications to use of midazolam and fentanyl 3) Using any opioids 4) Severe hypoxemia or hypercapnia 5) History of severe heart, lung, liver, kidney, neuromuscular disease 6) History of epilepsy 7) History of symptomatic cerebral infarction 8) During pregnancy or possible pregnancy 9) Emergency procedure 10) Bronchoscopy other than EBUS-GS 11) Other conditions inappropriate for participating in the study

Design outcomes

Primary

Measure	Time frame
The patient satisfaction score 2 hours after bronchoscopy using a visual analogue scale (VAS)	—

Countries

Japan

Contacts

Public ContactTakahide Kato

Ehime University School of Medicine Department of Cardiology, Pulmonology, Hypertension and Nephrology

kato.takahide.tn@ehime-u.ac.jp089-960-5303

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026